These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7097268)

  • 61. Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder.
    Rajkumar RP
    Case Rep Psychiatry; 2014; 2014():215732. PubMed ID: 25478273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent haloperidol withdrawal and benztropine overdose: a case report.
    West RR; Newgreen DB
    Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041
    [No Abstract]   [Full Text] [Related]  

  • 63. Differential effects of agents which alter CNS monoamine levels upon acoustic responses in the basal ganglia of freely moving rats.
    Dafny N; Dauth G; Gilman S
    Int J Neurol; 1975; 10(1-4):53-67. PubMed ID: 1181320
    [No Abstract]   [Full Text] [Related]  

  • 64. Denervation supersensitivity and the delay phenomenon.
    Cutting CB
    Plast Reconstr Surg; 1978 Sep; 62(3):442. PubMed ID: 693673
    [No Abstract]   [Full Text] [Related]  

  • 65. Supersensitivity psychosis with concurrent episodic vomiting.
    Malcolm K
    Br J Psychiatry; 1992 Sep; 161():407-9. PubMed ID: 1356574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Life events precipitating mania.
    Kennedy S; Thompson R; Stancer HC; Roy A; Persad E
    Br J Psychiatry; 1983 Apr; 142():398-403. PubMed ID: 6850179
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dopamine receptor agonists in psychiatric disease.
    Arbuthnott GW; Murray LG
    Adv Neurol; 1975; 9():345-8. PubMed ID: 1146659
    [No Abstract]   [Full Text] [Related]  

  • 68. Confusional paranoid psychosis after withdrawal from sympathomimetic amines: two case reports.
    Deveaugh-Geiss J; Pandurangi A
    Am J Psychiatry; 1982 Sep; 139(9):1190-1. PubMed ID: 7114316
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reserpine: cause and treatment of oral-facial dyskinesia.
    Wolf SM
    Bull Los Angeles Neurol Soc; 1973 Apr; 38(2):80-4. PubMed ID: 4702802
    [No Abstract]   [Full Text] [Related]  

  • 70. Denervation supersensitivity and the delay phenomenon.
    Cutting CB; Robson MC; Koss N
    Plast Reconstr Surg; 1978 Jun; 61(6):881-7. PubMed ID: 351639
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Reserpine- pros and cons].
    Hitzenberger G
    Wien Med Wochenschr; 1984 May; 134(9-10):222-5. PubMed ID: 6741164
    [No Abstract]   [Full Text] [Related]  

  • 72. Relative humidity and manic admissions in the London area.
    Mawson D; Smith A
    Br J Psychiatry; 1981 Feb; 138():134-8. PubMed ID: 7260493
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Electrical activity of the prepyriform cortex after reserpine in the rat.
    Williams B; Woolley DE; Timiras PS
    J Pharmacol Exp Ther; 1965 Oct; 150(1):10-6. PubMed ID: 5322548
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex.
    Hökfelt T; Fuxe K; Johansson O; Ljungdahl A
    Eur J Pharmacol; 1974 Jan; 25(1):108-12. PubMed ID: 4435009
    [No Abstract]   [Full Text] [Related]  

  • 75. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.
    Fukai M; Hirosawa T; Takahashi T; Kaneda R; Kikuchi M; Minabe Y
    Ther Adv Psychopharmacol; 2017 Mar; 7(3):113-117. PubMed ID: 28348731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thioridazine pharmacodynamics: clinical effects may depend upon drug metabolism.
    Lewis MH; Mobilio JN; Rissmiller DJ; Mailman RB
    J Am Osteopath Assoc; 1984 Sep; 84(1 Suppl):124-8. PubMed ID: 6490416
    [No Abstract]   [Full Text] [Related]  

  • 77. [Depression in patients treated with reserpine, still a reality].
    Wålinder J; Wallin L
    Lakartidningen; 1971 Mar; 68(14):1562-3. PubMed ID: 5576108
    [No Abstract]   [Full Text] [Related]  

  • 78. Withdrawal symptoms from chronic use of low-dose barbiturates.
    Epstein RS
    Am J Psychiatry; 1980 Jan; 137(1):107-8. PubMed ID: 7352542
    [No Abstract]   [Full Text] [Related]  

  • 79. The effect of reserpine on the vesicle content of Helix aspersa cerebral ganglia.
    Curtis DJ; Kerkut GA
    Comp Biochem Physiol; 1969 Sep; 30(5):835-40. PubMed ID: 5347602
    [No Abstract]   [Full Text] [Related]  

  • 80. [Ill effect of reserpine on bronchial asthma].
    Fueki R; Masaya M; Kobayashi T; Taya T; Katsura H
    Naika; 1969 May; 23(5):928-30. PubMed ID: 5807904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.